Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 10:01 PM ET

Date/Time Source News Release
05/13/2025 07:05 AM EDT GlobeNewswire Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
05/07/2025 08:05 AM EDT GlobeNewswire Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025
04/30/2025 08:05 AM EDT GlobeNewswire Cellectar Announces Plan to Explore Strategic Alternatives
03/13/2025 07:05 AM EDT GlobeNewswire Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
03/11/2025 08:05 AM EDT GlobeNewswire Cellectar Biosciences to Present at the 37th Annual Roth Conference
03/05/2025 08:05 AM EST GlobeNewswire Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025
02/05/2025 08:05 AM EST GlobeNewswire Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/12/2025 06:00 PM EST GlobeNewswire Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference
12/10/2024 05:00 PM EST GlobeNewswire Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring
11/18/2024 07:05 AM EST GlobeNewswire Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
Page

Additional News

As of June 3, 2025 • 10:01 PM ET

Date/Time Source News Release
05/22/2025 09:36 AM EDT Zacks Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
05/21/2025 11:37 AM EDT Zacks 4 Medical Product Stocks to Watch From a Challenging Industry
05/13/2025 02:17 PM EDT SeekingAlpha Cellectar signals Q3 EMA decision for conditional iopofosine approval while advancing pipeline and exploring strategic alternatives
05/13/2025 02:17 PM EDT SeekingAlpha Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call Transcript
05/13/2025 07:07 AM EDT SeekingAlpha Cellectar Biosciences GAAP EPS of -$0.14 beats by $0.02
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cellectar Biosciences Inc.
05/12/2025 12:08 PM EDT SeekingAlpha Cellectar Biosciences Q1 2025 Earnings Preview
04/17/2025 08:52 AM EDT Zacks 4 Medical Product Stocks to Buy From a Challenging Industry
03/18/2025 09:40 AM EDT Zacks Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.